Harmony Biosciences Holdings (HRMY) — Financial Flexibility Index
Harmony Biosciences Holdings (HRMY) has a Financial Flexibility Index of 0.29x as of September 2025. Free cash flow of $108.81 Million (operating CF $108.73 Million minus capex $71.00K) represents 0% of total liabilities ($373.10 Million). Also explore HRMY year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Harmony Biosciences Holdings Financial Flexibility Index (2018–2024)
Historical Financial Flexibility Index trend for Harmony Biosciences Holdings across 7 annual periods. Check Harmony Biosciences Holdings (HRMY) strategic investment index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Harmony Biosciences Holdings (2018–2024)
Year-by-year free cash flow to debt coverage for Harmony Biosciences Holdings. For the full company profile including market capitalisation, see HRMY company net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.65x | $220.97 Million | $219.82 Million | $340.05 Million | ▲ +1.9% |
| 2023 | 0.64x | $219.70 Million | $219.39 Million | $344.46 Million | ▲ +19.5% |
| 2022 | 0.53x | $144.64 Million | $144.47 Million | $271.03 Million | ▲ +33.3% |
| 2021 | 0.40x | $98.86 Million | $98.56 Million | $246.94 Million | ▲ +13534.9% |
| 2020 | 0.00x | $-983.00K | $-2.98 Million | $329.89 Million | ▲ +99.5% |
| 2019 | -0.64x | $-75.29 Million | $-75.44 Million | $118.29 Million | ▲ +86.8% |
| 2018 | -4.83x | $-37.46 Million | $-38.80 Million | $7.75 Million | — |